BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8476567)

  • 1. The molecular basis of allorecognition.
    Sherman LA; Chattopadhyay S
    Annu Rev Immunol; 1993; 11():385-402. PubMed ID: 8476567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes.
    Lombardi G; Lechler R
    Ann Ist Super Sanita; 1991; 27(1):7-14. PubMed ID: 1958030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of T-cell alloreactivity.
    Felix NJ; Allen PM
    Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between MHC restricted and allospecific T cell recognition.
    Lechler R; Batchelor R; Lombardi G
    Immunol Lett; 1991 Jul; 29(1-2):41-50. PubMed ID: 1916923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
    Smith KD; Lutz CT
    J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structural basis of T-cell allorecognition.
    Whitelegg A; Barber LD
    Tissue Antigens; 2004 Feb; 63(2):101-8. PubMed ID: 14705981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of self-peptides in direct T cell allorecognition.
    Abdelsamed HA; Lakkis FG
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of alloreactivity.
    Lechler RI; Lombardi G; Batchelor JR; Reinsmoen N; Bach FH
    Immunol Today; 1990 Mar; 11(3):83-8. PubMed ID: 2186745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of class II MHC allelic control of T cell responses.
    Racioppi L; Ronchese F; Schwartz RH; Germain RN
    J Immunol; 1991 Dec; 147(11):3718-27. PubMed ID: 1658150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.
    Marrack P; Kappler J
    Nature; 1988 Apr; 332(6167):840-3. PubMed ID: 3258650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic core amino acids of an immunodominant allopeptide are important for MHC binding and TCR recognition.
    Sitaru AG; Timmermann W; Ulrichs K; Otto C
    Hum Immunol; 2004 Aug; 65(8):817-25. PubMed ID: 15336783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopeptide-specific T cell reactivity altered by peptide analogs.
    Colovai AI; Liu Z; Harris PE; Cortesini R; Suciu-Foca N
    J Immunol; 1997 Jan; 158(1):48-54. PubMed ID: 8977174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell allorecognition and MHC restriction--A case of Jekyll and Hyde?
    Archbold JK; Ely LK; Kjer-Nielsen L; Burrows SR; Rossjohn J; McCluskey J; Macdonald WA
    Mol Immunol; 2008 Feb; 45(3):583-98. PubMed ID: 17869342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule.
    Reiser JB; Darnault C; Guimezanes A; Grégoire C; Mosser T; Schmitt-Verhulst AM; Fontecilla-Camps JC; Malissen B; Housset D; Mazza G
    Nat Immunol; 2000 Oct; 1(4):291-7. PubMed ID: 11017099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell allorecognition: a case of mistaken identity or déjà vu?
    Archbold JK; Macdonald WA; Burrows SR; Rossjohn J; McCluskey J
    Trends Immunol; 2008 May; 29(5):220-6. PubMed ID: 18378495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of peptide antigens and class II major histocompatibility complex antigens.
    Guillet JG; Lai MZ; Briner TJ; Smith JA; Gefter ML
    Nature; 1986 Nov 20-26; 324(6094):260-2. PubMed ID: 2946957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes.
    Heath WR; Hurd ME; Carbone FR; Sherman LA
    Nature; 1989 Oct; 341(6244):749-52. PubMed ID: 2477713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.